Rationale and Design of the ADVOR (Acetazolamide in Decompensated Heart Failure With Volume Overload) Trial

European Journal of Heart Failure - United States
doi 10.1002/ejhf.1307
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pharmacological and Non-Pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article

Cureus
2020English

Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) Trial: Design and Rationale

American Heart Journal
Cardiovascular MedicineCardiology
2017English

Heart Failure: Distinguishing Failing Myocardium From Volume Overload

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Effect of Nesiritide in Patients With Acute Decompensated Heart Failure

New England Journal of Medicine
Medicine
2011English

Upregulation of -Adrenergic Receptors in Heart Failure Due to Volume Overload

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2005English

Endothelial Cell Activation in Patients With Decompensated Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Rationale and Design of the Multicentre, Randomized, Double-Blind, Placebo-Controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2011English

Risk Stratification in Acute Heart Failure: Rationale and Design of the STRATIFY and DECIDE Studies

American Heart Journal
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy